Anonymous
Guest
Anonymous
Guest
Novartis is working an getting exclusive rights to a new BCR/Able test from Europe. They claim that it is FDA cleared. Betya thats what Genoptix reps will be selling for the next few years!
This is the main threat of this merger, "exclusive licensed tests"
This is the main threat of this merger, "exclusive licensed tests"